Table 3.

Comparison of MM-positive and MM-negative groups

	RT-qPCR expression (n, %)		P
	Positive	Negative
Gender			NS
Male	2 (50 %)	8 (80 %)
Female	2 (50 %)	2 (20 %)
Age (years)	55 ± 8.7	69 ± 8.9	0.019
Lauren type			0.037
Intestinal	0 (0 %)	8 (88.9 %)
Diffuse	2 (66.7 %)	0 (0 %)
Mixed	1 (33.3 %)	1 (11.1 %)
Tumor third			NS
Mid third	2 (50 %)	2 (22.2 %)
Lower third	2 (50 %)	7 (77.8 %)
Tumor site			NS
Lesser	2 (50 %)	3 (30 %)
Greater	1 (25 %)	2 (20 %)
Anterior	0 (0 %)	1 (10 %)
Posterior	1 (25 %)	3 (30 %)
Circular	0 (0 %)	1 (10 %)
EGC type			NS
I	1 (50 %)	1 (14.3 %)
IIb	0 (0 %)	2 (28.6 %)
IIc	1 (50 %)	2 (28.6 %)
III	0 (0 %)	2 (28.6 %)
Bormann type			NS
III	1 (50 %)	2 (66.7 %)
IV	1 (50 %)	1 (33.3 %)
T stage			NS
T1a	1 (25 %)	4 (40 %)
T1b	1 (25 %)	2 (20 %)
T2	1 (25 %)	3 (30 %)
T3	1 (25 %)	1 (10 %)
Differentiation			NS
Tubular well	0 (0 %)	3 (33.3 %)
Tubular moderate	1 (33.3 %)	2 (22.2 %)
Tubular poor	2 (66.7 %)	3 (33.3.%)
Signet ring-cell	0 (0 %)	1 (11.1 %)
Lymphangial invasion			NS
Negative	4 (100 %)	9 (90 %)
Positive	0 (0 %)	1 (10 %)
Vascular invasion			NS
Negative	4 (100 %)	10 (100 %)
Positive	0 (0 %)	0 (0 %)
Perineural invasion			NS
Negative	3 (75 %)	8 (80 %)
Positive	1 (25 %)	2 (20 %)
Extranodal infiltration			NS
Negative	4 (100 %)	10 (100 %)
Positive	0 (0 %)	0 (0 %)
CEA (ng/ml)	1 ± 0	1.57 ± 1.3	NS
AFP (ng/ml)	3 ± 1.7	3.8 ± 2.2	NS
CA 19-9 (ng/ml)	22 ± 17.8	4 ± 5	NS
Tumor size (mm)	30 ± 12	35 ± 25.5	NS
Number of extracted lymph nodes	13 ± 9.8	12 ± 7.5	NS
Proportion of positive lymph nodes (%)	52 ± 43.7	26 ± 28.2	NS